From new rescue agreements to courtroom battles and bipartisan legislation, the movement to end animal experimentation is gaining ground.
The movement to end animal testing is entering a consequential new chapter. In recent weeks, Marshall BioResources has expanded its relationships with animal rescues, hundreds of advocates have gathered outside its New York headquarters, and federal lawmakers have introduced legislation challenging the use of dogs and cats in government-funded research.
The developments follow mounting scrutiny of Marshall BioResources, one of the country’s largest suppliers of animals for laboratory research. As previously reported by The Humane Herald, the company has faced whistleblower allegations, calls for federal investigation, and growing questions about the future of animal experimentation.
Now, some of that pressure is producing visible changes.
New Beginnings for Beagles
In September, Marshall BioResources released 10 retired breeding dogs, with five placed through Paws of War and five through Florida-based Big Dog Ranch Rescue, according to research provided to The Humane Herald.
On September 21, Kindness Ranch also announced a long-term agreement with Marshall to receive retired breeding beagles and potentially other animals. The publicly acknowledged arrangement represents a noteworthy development for a company whose business has historically centered on supplying animals to laboratories.
Marshall has not announced plans to discontinue breeding animals for research. Nevertheless, these agreements offer something previously unavailable to many of the animals involved: the opportunity for a life outside the industry.
Meanwhile, the March to Abolish Animal Testing completed its 207-mile journey across New York on September 26, culminating in a demonstration outside Marshall’s North Rose headquarters. Hundreds gathered for the event, according to eyewitness accounts, bringing renewed attention to the thousands of animals housed at the facility.
In a September interview with the Times of Wayne County, Marshall BioResources CEO Scott Marshall acknowledged the industry’s growing investment in alternative research methods, while maintaining that animal experimentation remains necessary.
“I know the writing is on the wall,” Marshall said.
Rescue Cases Raise Difficult Legal Questions
Courtrooms are becoming another battleground.
In March, five activists were acquitted in England after standing trial for rescuing 18 beagle puppies from MBR Acres. Following seven days of testimony and more than nine hours of deliberation, jurors returned not-guilty verdicts.
In Wisconsin, four defendants connected to a March rescue at Ridglan Farms face a different legal outcome. Their trials have been delayed until January 2027, while prosecutors have sought to prevent jurors from hearing certain evidence about conditions at the facility.
Ridglan has since closed its breeding operations, but the criminal cases continue.
The dispute raises a significant question about animal rescue prosecutions: Should the conditions that motivated an alleged unlawful rescue be considered when determining criminal responsibility?
Congress Considers a New Direction
Legislative pressure is also growing. On September 21, Representatives Nick Langworthy (R-NY) and Mark Pocan (D-WI) introduced the bipartisan Companion Animal Protection Against Cruel Testing Act, or COMPACT Act.
The legislation would generally prohibit the use of Department of Health and Human Services funding for biomedical research involving live dogs and cats, with specified exceptions. It would also strengthen reporting and accountability requirements.
The bill does not ban animal testing outright, but it represents another challenge to the assumption that publicly funded biomedical research must continue relying on companion animals.
Advocates can contact their congressional representatives through Save the Dogs to request support for the legislation.
A Changing Industry, an Unfinished Fight
The animal testing industry is not disappearing overnight. Thousands of animals remain in breeding facilities and laboratories, rescue defendants face unresolved legal proceedings, and the COMPACT Act has yet to become law.
Still, the developments are difficult to dismiss. Rescue agreements are expanding, courtroom debates are reaching new audiences, and bipartisan lawmakers are questioning established research practices.
The question is no longer simply whether animal experimentation can be reduced.
It is whether an industry increasingly confronted with alternatives can justify continuing business as usual.
Editor’s Note: This article was developed with research contributions from Humane Party volunteer Jennifer Paul, whose ongoing monitoring of rescue efforts, legal proceedings, legislative developments, and animal advocacy campaigns helped inform The Humane Herald’s continuing coverage of Marshall BioResources and the movement to end animal experimentation.
